| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Intra-Cellular Therapies Inc (NASDAQ: ITCI)
ITCI Technical Analysis
5
| As on 9th Jun 2023 ITCI STOCK Price closed @ 65.82 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 52.76 & Strong Buy for SHORT-TERM with Stoploss of 49.48 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ITCISTOCK Price
| Open | 64.97 | Change | Price | % |
| High | 65.93 | 1 Day | 0.54 | 0.83 |
| Low | 64.70 | 1 Week | 6.44 | 10.85 |
| Close | 65.82 | 1 Month | 3.95 | 6.38 |
| Volume | 476000 | 1 Year | 17.62 | 36.56 |
| 52 Week High 66.44 | 52 Week Low 38.74 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ITCI Daily Charts |
ITCI Intraday Charts |
Whats New @ Bazaartrend |
ITCI Free Analysis |
|
|
ITCI Important Levels Intraday
| RESISTANCE | 68.19 |
| RESISTANCE | 67.43 |
| RESISTANCE | 66.96 |
| RESISTANCE | 66.49 |
| SUPPORT | 65.15 |
| SUPPORT | 64.68 |
| SUPPORT | 64.21 |
| SUPPORT | 63.45 |
ITCI Forecast May 2024
| 4th UP Forecast | 103.8 |
| 3rd UP Forecast | 91.62 |
| 2nd UP Forecast | 84.09 |
| 1st UP Forecast | 76.56 |
| 1st DOWN Forecast | 55.08 |
| 2nd DOWN Forecast | 47.55 |
| 3rd DOWN Forecast | 40.02 |
| 4th DOWN Forecast | 27.84 |
ITCI Weekly Forecast
| 4th UP Forecast | 90.25 |
| 3rd UP Forecast | 82.42 |
| 2nd UP Forecast | 77.57 |
| 1st UP Forecast | 72.73 |
| 1st DOWN Forecast | 58.91 |
| 2nd DOWN Forecast | 54.07 |
| 3rd DOWN Forecast | 49.22 |
| 4th DOWN Forecast | 41.39 |
ITCI Forecast2024
| 4th UP Forecast | 119.87 |
| 3rd UP Forecast | 102.54 |
| 2nd UP Forecast | 91.82 |
| 1st UP Forecast | 81.11 |
| 1st DOWN Forecast | 50.53 |
| 2nd DOWN Forecast | 39.82 |
| 3rd DOWN Forecast | 29.1 |
| 4th DOWN Forecast | 11.77 |
Intra-Cellular Therapies Inc ( NASDAQ USA Symbol : ITCI )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ITCI Business Profile
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the central nervous system (CNS) in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also developing lumateperone, which is in Phase 3 clinical trials for the treatment of bipolar depression, as well as to treat autism spectrum disorder, and sleep disorders associated with neuropsychiatric and neurological disorders. In addition, the company is developing ITI-002 that inhibits the enzyme phosphodiesterase type 1; ITI-214 for the treatment of Parkinson's disease and heart failure; ITI-1284 for the treatment of neuropsychiatric disorders and behavioral disturbances in dementia; and ITI-333, for substance use disorders, pain, and psychiatric comorbidities, including depression and anxiety. Intra-Cellular Therapies, Inc. is headquartered in New York, New York. Address: 430 East 29th Street, New York, NY, United States, 10016
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service